RNAC·Nasdaq·US
Cartesian Therapeutics
Cartesian Therapeutics is a late clinical-stage biotechnology company developing mRNA-enabled cell therapies for autoimmune diseases. Its lead program, Descartes-08, is a CAR-T candidate in clinical development for indications including generalized myasthenia gravis and other autoimmune conditions.
Thematic Position
Relationship Groups
Relationship details are part of the Pro plan.
Recent Discoveries
Recent discoveries are part of the Pro plan.